Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)
Top Cited Papers
- 28 February 2013
- journal article
- review article
- Published by Elsevier BV in The Lancet Neurology
- Vol. 12 (2), 186-194
- https://doi.org/10.1016/s1474-4422(12)70296-x
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Role of expression site switching in the development of resistance to human Trypanosome Lytic Factor-1 in Trypanosoma brucei bruceiMolecular and Biochemical Parasitology, 2012
- Differences between Trypanosoma brucei gambiense Groups 1 and 2 in Their Resistance to Killing by Trypanolytic Factor 1PLoS Neglected Tropical Diseases, 2011
- Using Detergent to Enhance Detection Sensitivity of African Trypanosomes in Human CSF and Blood by Loop-Mediated Isothermal Amplification (LAMP)PLoS Neglected Tropical Diseases, 2011
- Prevalence of Human African Trypanosomiasis in the Democratic Republic of the CongoPLoS Neglected Tropical Diseases, 2011
- Human host determinants influencing the outcome of Trypanosoma brucei gambiense infectionsParasite Immunology, 2011
- Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trialThe Lancet, 2009
- Eliminating Human African Trypanosomiasis: Where Do We Stand and What Comes Next?PLoS Medicine, 2008
- Loop-Mediated Isothermal Amplification (LAMP) Method for Rapid Detection of Trypanosoma brucei rhodesiensePLoS Neglected Tropical Diseases, 2008
- Spatially and Genetically Distinct African Trypanosome Virulence Variants Defined by Host Interferon‐γ ResponseThe Journal of Infectious Diseases, 2007
- Sleeping sickness in Uganda: a thin line between two fatal diseasesBMJ, 2005